"At our Oceanside, NY location, you can expect to receive the best care possible. With years of experience, our Oceanside eye care experts are here to make sure you get the care you need. Our doctors provide procedures such as cataract surgery and LASIK, as well as glaucoma and oculoplastic procedures. To book an eye care appointment with an ophthalmologist at our Oceanside location, please give us a call. You can also request an appointment online!"

During the past decade, Ophthalmic Consultants of Long Island conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ophthalmic Consultants of Long Island" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Kodiak Sciences Inc" with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Ophthalmic Consultants of Long Island" are "Diabetic Macular Edema" (4 trials), "Age-Related Macular Degeneration" (1 trials), "Diabetic Retinopathy" (1 trials), "Geographic Atrophy Secondary to Age-related Macular Degeneration" (1 trials) and "Macular Degeneration" (1 trials). Many other conditions were trialed in "Ophthalmic Consultants of Long Island" in a lesser frequency.

Most popular intervention types in "Ophthalmic Consultants of Long Island" are "Drug" (11 trials), "Other" (6 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Faricimab" (4 trials), "KSI-301" (2 trials) and "Abicipar Pegol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ophthalmic Consultants of Long Island" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Ophthalmic Consultants of Long Island". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ophthalmic Consultants of Long Island, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ophthalmic Consultants of Long Island, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".